A panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The meeting is the ...

The FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD), calling for another trial to evaluate the drug's efficacy and safety, developer Lykos Therapeutics ...

FILE - In this photo made with a long exposure, a man is silhouetted against lights reflected in the waters off Cape Neddick in Maine on Dec. 11, 2017. Federal health advisers are considering the ...

Lykos Therapeutics is cutting 75% of staff after FDA rejected its MDMA drug for mental health. The FDA's decision marks the first time the agency considered a psychedelic for medical use. Lykos plans ...

New York — It was a landmark moment for the psychedelic movement: The Department of Veteran Affairs’ top doctor stood on stage, praising advocates who have spent decades promoting the healing ...

Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the banned drugs ...

WASHINGTON (AP) — Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD — part of a decadeslong effort by psychedelic ...

The Government’s new mandate for random oral-fluid roadside drug testing targets THC, cocaine, methamphetamine and MDMA.

Australia has made major progress in curbing drunk driving. Decades of random breath testing, enforcement and powerful social ...